The Endocrine Secretome After Gastric Bypass Surgery

NCT03093298 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2017-03-28

No results posted yet for this study

Summary

Examination of the molecular phenotype and composition of endocrine cells in the gastrointestinal tract correlated to analyses of blood for hormones/analytes before and after Roux-en-Y gastric bypass surgery in morbidly obese individuals both with and without type 2 diabetes

Conditions

  • Obesity, Morbid
  • Type2 Diabetes

Interventions

OTHER

Enteroscopy with biopsy sampling and mixed meal test

Enteroscopies with biopsy retrieval and mixed meal tests with blood sampling before and after Roux-en-Y gastric bypass surgery

Sponsors & Collaborators

  • Sanofi

    collaborator INDUSTRY
  • Filip Krag Knop

    lead OTHER

Principal Investigators

  • Filip Knop, MD, prof. · Gentofte Hospital, University of Copenhagen

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-12
Primary Completion
2016-12-13
Completion
2016-12-13

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03093298 on ClinicalTrials.gov